1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.

Repligen Corp.

XNAS: RGEN

Weak Stock
Download real time

131.55 -2.17 (-1.62%)

27.93% Fall from 52W High

546.9K XNAS Volume

XNAS 13 May, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
7S
16W
1O
2T
7,390.9

Market Cap

High in industry
-321.6

PE TTM

Negative PE TTM
1.6

PEG TTM

PEG TTM is much higher than 1
3.7

Price to Book

Below industry Median
0.1

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Repligen Corp. is on 16 May 2025 for the purpose of Repligen Corp Annual General Meeting for 2025 See details

Repligen Corp. - RGEN - stock price prediction, stock price target, analyst ratings from 19 analysts

Repligen Corp. has a share price target of US$ 183, revenue growth forecast of 11.7%, and profit growth estimate of 280.9% for FY25, based on top 19 analyst calls.

Forecaster Screeners